Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens–Johnson syndrome with severe ocular complications in Japanese individuals View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-10-28

AUTHORS

Mayumi Ueta, Ryosuke Nakamura, Yoshiro Saito, Katsushi Tokunaga, Chie Sotozono, Toshio Yabe, Michiko Aihara, Kayoko Matsunaga, Shigeru Kinoshita

ABSTRACT

Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute-onset mucocutaneous diseases induced by infectious agents and/or inciting drugs. We have reported that the main causative drugs for SJS/TEN with severe ocular complications (SOC) were cold medicines, including multi-ingredient cold medications and nonsteroidal anti-inflammatory drugs (NSAIDs). Moreover, we also reported that acetaminophen is the most frequent causative drug in various cold medicines. In this study, we focused on acetaminophen-related SJS/TEN with SOC and analyzed HLA-class II (HLA-DRB1, DQB1) in addition to HLA-class I (HLA-A, B, C). We studied the histocompatibility antigen genes HLA-DRB1 and DQB1 in addition to HLA-A, B, and C in 80 Japanese patients with acetaminophen-related SJS/TEN with SOC. We performed polymerase chain reaction amplification followed by hybridization with sequence-specific oligonucleotide probes (PCR-SSO) using commercial bead-based typing kits. We also used genotyped data from 113 healthy volunteers for HLA-DRB1 and DQB1, and 639 healthy volunteers for HLA-A, B, and C. HLA-DRB1*08:03 and DRB1*12:02 were associated with acetaminophen-related SJS/TEN with SOC, although the results ceased to be significant when we corrected the p-value for the number of alleles detected. HLA-A*02:06 was strongly associated with acetaminophen-related SJS/TEN with SOC (carrier frequency: p = 4.7 × 10−12, Pc = 6.6 × 10−11, OR = 6.0; gene frequency: p = 8.0 × 10−13, Pc = 1.1 × 10−11, OR = 4.9). HLA-B*13:01 (carrier frequency: p = 2.0 × 10−3, Pc = 0.042, OR = 4.1; gene frequency: p = 2.2 × 10−3, Pc = 0.047, OR = 3.9), HLA-B*44:03 (carrier frequency: p = 2.1 × 10−3, Pc = 0.045, OR = 2.4) and HLA-C*14:03 (carrier frequency: p = 3.4 × 10−3, Pc = 0.045, OR = 2.3) were also significantly associated, while HLA-A*24:02 was inversely associated (gene frequency: p = 6.3 × 10−4, Pc = 8.8 × 10−3, OR = 0.5). Acetaminophen-related SJS/TEN with SOC was not associated with HLA-class II (HLA-DRB1, DQB1). However, for acetaminophen-related SJS/TEN with SOC, we found an association with HLA-B*13:01 and HLA- C*14:03 in addition to HLA-A*02:06 and HLA-B*44:03, which have been described previously. More... »

PAGES

50

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41439-019-0082-6

DOI

http://dx.doi.org/10.1038/s41439-019-0082-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1122142832

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31666976


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueta", 
        "givenName": "Mayumi", 
        "id": "sg:person.0741226323.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741226323.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410797.c", 
          "name": [
            "Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakamura", 
        "givenName": "Ryosuke", 
        "id": "sg:person.015475136753.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015475136753.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410797.c", 
          "name": [
            "Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saito", 
        "givenName": "Yoshiro", 
        "id": "sg:person.0741220377.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741220377.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genome Medical Science Project (Toyama), National Center for Global Health and Medicine, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.45203.30", 
          "name": [
            "Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan", 
            "Genome Medical Science Project (Toyama), National Center for Global Health and Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tokunaga", 
        "givenName": "Katsushi", 
        "id": "sg:person.01215176214.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215176214.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sotozono", 
        "givenName": "Chie", 
        "id": "sg:person.0624777723.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624777723.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokyo Metropolitan Red Cross Blood Center, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Tokyo Metropolitan Red Cross Blood Center, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yabe", 
        "givenName": "Toshio", 
        "id": "sg:person.01245676554.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245676554.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.268441.d", 
          "name": [
            "Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aihara", 
        "givenName": "Michiko", 
        "id": "sg:person.01137320362.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137320362.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.256115.4", 
          "name": [
            "Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsunaga", 
        "givenName": "Kayoko", 
        "id": "sg:person.01063533667.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063533667.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kinoshita", 
        "givenName": "Shigeru", 
        "id": "sg:person.01016754101.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016754101.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ni1188", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005581325", 
          "https://doi.org/10.1038/ni1188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/srep05981", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003061255", 
          "https://doi.org/10.1038/srep05981"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/srep04862", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032179384", 
          "https://doi.org/10.1038/srep04862"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-10-28", 
    "datePublishedReg": "2019-10-28", 
    "description": "Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute-onset mucocutaneous diseases induced by infectious agents and/or inciting drugs. We have reported that the main causative drugs for SJS/TEN with severe ocular complications (SOC) were cold medicines, including multi-ingredient cold medications and nonsteroidal anti-inflammatory drugs (NSAIDs). Moreover, we also reported that acetaminophen is the most frequent causative drug in various cold medicines. In this study, we focused on acetaminophen-related SJS/TEN with SOC and analyzed HLA-class II (HLA-DRB1, DQB1) in addition to HLA-class I (HLA-A, B, C). We studied the histocompatibility antigen genes HLA-DRB1 and DQB1 in addition to HLA-A, B, and C in 80 Japanese patients with acetaminophen-related SJS/TEN with SOC. We performed polymerase chain reaction amplification followed by hybridization with sequence-specific oligonucleotide probes (PCR-SSO) using commercial bead-based typing kits. We also used genotyped data from 113 healthy volunteers for HLA-DRB1 and DQB1, and 639 healthy volunteers for HLA-A, B, and C. HLA-DRB1*08:03 and DRB1*12:02 were associated with acetaminophen-related SJS/TEN with SOC, although the results ceased to be significant when we corrected the p-value for the number of alleles detected. HLA-A*02:06 was strongly associated with acetaminophen-related SJS/TEN with SOC (carrier frequency: p\u2009=\u20094.7\u2009\u00d7\u200910\u221212, Pc\u2009=\u20096.6\u2009\u00d7\u200910\u221211, OR\u2009=\u20096.0; gene frequency: p\u2009=\u20098.0\u2009\u00d7\u200910\u221213, Pc\u2009=\u20091.1\u2009\u00d7\u200910\u221211, OR\u2009=\u20094.9). HLA-B*13:01 (carrier frequency: p\u2009=\u20092.0\u2009\u00d7\u200910\u22123, Pc\u2009=\u20090.042, OR\u2009=\u20094.1; gene frequency: p\u2009=\u20092.2\u2009\u00d7\u200910\u22123, Pc\u2009=\u20090.047, OR\u2009=\u20093.9), HLA-B*44:03 (carrier frequency: p\u2009=\u20092.1\u2009\u00d7\u200910\u22123, Pc\u2009=\u20090.045, OR\u2009=\u20092.4) and HLA-C*14:03 (carrier frequency: p\u2009=\u20093.4\u2009\u00d7\u200910\u22123, Pc\u2009=\u20090.045, OR\u2009=\u20092.3) were also significantly associated, while HLA-A*24:02 was inversely associated (gene frequency: p\u2009=\u20096.3\u2009\u00d7\u200910\u22124, Pc\u2009=\u20098.8\u2009\u00d7\u200910\u22123, OR\u2009=\u20090.5). Acetaminophen-related SJS/TEN with SOC was not associated with HLA-class II (HLA-DRB1, DQB1). However, for acetaminophen-related SJS/TEN with SOC, we found an association with HLA-B*13:01 and HLA- C*14:03 in addition to HLA-A*02:06 and HLA-B*44:03, which have been described previously.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41439-019-0082-6", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.8428869", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.9338102", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6532700", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.9339300", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1320608", 
        "issn": [
          "2054-345X"
        ], 
        "name": "Human Genome Variation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "SJS/toxic epidermal necrolysis", 
      "toxic epidermal necrolysis", 
      "severe ocular complications", 
      "Stevens-Johnson syndrome", 
      "nonsteroidal anti-inflammatory drugs", 
      "HLA class II", 
      "HLA class I", 
      "causative drugs", 
      "ocular complications", 
      "HLA-DRB1", 
      "healthy volunteers", 
      "cold medicines", 
      "multi-ingredient cold medications", 
      "main causative drugs", 
      "frequent causative drugs", 
      "anti-inflammatory drugs", 
      "sequence-specific oligonucleotide probes", 
      "epidermal necrolysis", 
      "mucocutaneous disease", 
      "Japanese patients", 
      "histocompatibility antigens", 
      "cold medications", 
      "infectious agents", 
      "HLA", 
      "gene polymorphisms", 
      "polymerase chain reaction amplification", 
      "chain reaction amplification", 
      "class I", 
      "drugs", 
      "acetaminophen", 
      "complications", 
      "Japanese individuals", 
      "syndrome", 
      "p-value", 
      "DQB1", 
      "reaction amplification", 
      "volunteers", 
      "typing kit", 
      "association", 
      "medicine", 
      "necrolysis", 
      "medications", 
      "patients", 
      "antigen", 
      "disease", 
      "kit", 
      "polymorphism", 
      "agents", 
      "oligonucleotide probes", 
      "addition", 
      "individuals", 
      "alleles", 
      "study", 
      "amplification", 
      "hybridization", 
      "data", 
      "number", 
      "results", 
      "probe", 
      "number of alleles"
    ], 
    "name": "Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens\u2013Johnson syndrome with severe ocular complications in Japanese individuals", 
    "pagination": "50", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1122142832"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41439-019-0082-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31666976"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41439-019-0082-6", 
      "https://app.dimensions.ai/details/publication/pub.1122142832"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_823.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41439-019-0082-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41439-019-0082-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41439-019-0082-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41439-019-0082-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41439-019-0082-6'


 

This table displays all metadata directly associated to this object as RDF triples.

214 TRIPLES      21 PREDICATES      88 URIs      77 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41439-019-0082-6 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author Ne92475aa731a49de8c4d50c0b7c25dd7
4 schema:citation sg:pub.10.1038/ni1188
5 sg:pub.10.1038/srep04862
6 sg:pub.10.1038/srep05981
7 schema:datePublished 2019-10-28
8 schema:datePublishedReg 2019-10-28
9 schema:description Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute-onset mucocutaneous diseases induced by infectious agents and/or inciting drugs. We have reported that the main causative drugs for SJS/TEN with severe ocular complications (SOC) were cold medicines, including multi-ingredient cold medications and nonsteroidal anti-inflammatory drugs (NSAIDs). Moreover, we also reported that acetaminophen is the most frequent causative drug in various cold medicines. In this study, we focused on acetaminophen-related SJS/TEN with SOC and analyzed HLA-class II (HLA-DRB1, DQB1) in addition to HLA-class I (HLA-A, B, C). We studied the histocompatibility antigen genes HLA-DRB1 and DQB1 in addition to HLA-A, B, and C in 80 Japanese patients with acetaminophen-related SJS/TEN with SOC. We performed polymerase chain reaction amplification followed by hybridization with sequence-specific oligonucleotide probes (PCR-SSO) using commercial bead-based typing kits. We also used genotyped data from 113 healthy volunteers for HLA-DRB1 and DQB1, and 639 healthy volunteers for HLA-A, B, and C. HLA-DRB1*08:03 and DRB1*12:02 were associated with acetaminophen-related SJS/TEN with SOC, although the results ceased to be significant when we corrected the p-value for the number of alleles detected. HLA-A*02:06 was strongly associated with acetaminophen-related SJS/TEN with SOC (carrier frequency: p = 4.7 × 10−12, Pc = 6.6 × 10−11, OR = 6.0; gene frequency: p = 8.0 × 10−13, Pc = 1.1 × 10−11, OR = 4.9). HLA-B*13:01 (carrier frequency: p = 2.0 × 10−3, Pc = 0.042, OR = 4.1; gene frequency: p = 2.2 × 10−3, Pc = 0.047, OR = 3.9), HLA-B*44:03 (carrier frequency: p = 2.1 × 10−3, Pc = 0.045, OR = 2.4) and HLA-C*14:03 (carrier frequency: p = 3.4 × 10−3, Pc = 0.045, OR = 2.3) were also significantly associated, while HLA-A*24:02 was inversely associated (gene frequency: p = 6.3 × 10−4, Pc = 8.8 × 10−3, OR = 0.5). Acetaminophen-related SJS/TEN with SOC was not associated with HLA-class II (HLA-DRB1, DQB1). However, for acetaminophen-related SJS/TEN with SOC, we found an association with HLA-B*13:01 and HLA- C*14:03 in addition to HLA-A*02:06 and HLA-B*44:03, which have been described previously.
10 schema:genre article
11 schema:isAccessibleForFree true
12 schema:isPartOf N072d4916942345e2bb0a0fee4ba934c2
13 N32ec99bc2fe94885aae0b3897b488aa9
14 sg:journal.1320608
15 schema:keywords DQB1
16 HLA
17 HLA class I
18 HLA class II
19 HLA-DRB1
20 Japanese individuals
21 Japanese patients
22 SJS/toxic epidermal necrolysis
23 Stevens-Johnson syndrome
24 acetaminophen
25 addition
26 agents
27 alleles
28 amplification
29 anti-inflammatory drugs
30 antigen
31 association
32 causative drugs
33 chain reaction amplification
34 class I
35 cold medications
36 cold medicines
37 complications
38 data
39 disease
40 drugs
41 epidermal necrolysis
42 frequent causative drugs
43 gene polymorphisms
44 healthy volunteers
45 histocompatibility antigens
46 hybridization
47 individuals
48 infectious agents
49 kit
50 main causative drugs
51 medications
52 medicine
53 mucocutaneous disease
54 multi-ingredient cold medications
55 necrolysis
56 nonsteroidal anti-inflammatory drugs
57 number
58 number of alleles
59 ocular complications
60 oligonucleotide probes
61 p-value
62 patients
63 polymerase chain reaction amplification
64 polymorphism
65 probe
66 reaction amplification
67 results
68 sequence-specific oligonucleotide probes
69 severe ocular complications
70 study
71 syndrome
72 toxic epidermal necrolysis
73 typing kit
74 volunteers
75 schema:name Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens–Johnson syndrome with severe ocular complications in Japanese individuals
76 schema:pagination 50
77 schema:productId N5bb474a3e369485798e796ccf0317844
78 N892837d9d6ea4e7188b780fd07bc9900
79 Nc63ccea6c7b2464da582f33cb6666637
80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1122142832
81 https://doi.org/10.1038/s41439-019-0082-6
82 schema:sdDatePublished 2022-08-04T17:09
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher N6819ceca81a049bfa6663adf49505fde
85 schema:url https://doi.org/10.1038/s41439-019-0082-6
86 sgo:license sg:explorer/license/
87 sgo:sdDataset articles
88 rdf:type schema:ScholarlyArticle
89 N072d4916942345e2bb0a0fee4ba934c2 schema:issueNumber 1
90 rdf:type schema:PublicationIssue
91 N0d94dfd45d174c6495f0da89d1a0087f rdf:first sg:person.015475136753.68
92 rdf:rest N34cf5f53c8694e9d9716b67b3910b9af
93 N14a3f870f5f04d5199589b96066668ef rdf:first sg:person.01215176214.31
94 rdf:rest Na1989c8c689c4691a67a21d9cad44db0
95 N1584b63b037d4328accb28a7934caf0f rdf:first sg:person.01063533667.24
96 rdf:rest Nb9d7dcf91e874e649bcf23cafaa08fe6
97 N32ec99bc2fe94885aae0b3897b488aa9 schema:volumeNumber 6
98 rdf:type schema:PublicationVolume
99 N34cf5f53c8694e9d9716b67b3910b9af rdf:first sg:person.0741220377.47
100 rdf:rest N14a3f870f5f04d5199589b96066668ef
101 N441a049fb7bf413599a2c46203fde974 rdf:first sg:person.01137320362.23
102 rdf:rest N1584b63b037d4328accb28a7934caf0f
103 N5bb474a3e369485798e796ccf0317844 schema:name doi
104 schema:value 10.1038/s41439-019-0082-6
105 rdf:type schema:PropertyValue
106 N6819ceca81a049bfa6663adf49505fde schema:name Springer Nature - SN SciGraph project
107 rdf:type schema:Organization
108 N892837d9d6ea4e7188b780fd07bc9900 schema:name dimensions_id
109 schema:value pub.1122142832
110 rdf:type schema:PropertyValue
111 Na1989c8c689c4691a67a21d9cad44db0 rdf:first sg:person.0624777723.12
112 rdf:rest Nf044cb330483419e86cdf351ca2d6c90
113 Nb9d7dcf91e874e649bcf23cafaa08fe6 rdf:first sg:person.01016754101.20
114 rdf:rest rdf:nil
115 Nc63ccea6c7b2464da582f33cb6666637 schema:name pubmed_id
116 schema:value 31666976
117 rdf:type schema:PropertyValue
118 Ne92475aa731a49de8c4d50c0b7c25dd7 rdf:first sg:person.0741226323.70
119 rdf:rest N0d94dfd45d174c6495f0da89d1a0087f
120 Nf044cb330483419e86cdf351ca2d6c90 rdf:first sg:person.01245676554.49
121 rdf:rest N441a049fb7bf413599a2c46203fde974
122 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
123 schema:name Medical and Health Sciences
124 rdf:type schema:DefinedTerm
125 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
126 schema:name Pharmacology and Pharmaceutical Sciences
127 rdf:type schema:DefinedTerm
128 sg:grant.6532700 http://pending.schema.org/fundedItem sg:pub.10.1038/s41439-019-0082-6
129 rdf:type schema:MonetaryGrant
130 sg:grant.8428869 http://pending.schema.org/fundedItem sg:pub.10.1038/s41439-019-0082-6
131 rdf:type schema:MonetaryGrant
132 sg:grant.9338102 http://pending.schema.org/fundedItem sg:pub.10.1038/s41439-019-0082-6
133 rdf:type schema:MonetaryGrant
134 sg:grant.9339300 http://pending.schema.org/fundedItem sg:pub.10.1038/s41439-019-0082-6
135 rdf:type schema:MonetaryGrant
136 sg:journal.1320608 schema:issn 2054-345X
137 schema:name Human Genome Variation
138 schema:publisher Springer Nature
139 rdf:type schema:Periodical
140 sg:person.01016754101.20 schema:affiliation grid-institutes:grid.272458.e
141 schema:familyName Kinoshita
142 schema:givenName Shigeru
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016754101.20
144 rdf:type schema:Person
145 sg:person.01063533667.24 schema:affiliation grid-institutes:grid.256115.4
146 schema:familyName Matsunaga
147 schema:givenName Kayoko
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063533667.24
149 rdf:type schema:Person
150 sg:person.01137320362.23 schema:affiliation grid-institutes:grid.268441.d
151 schema:familyName Aihara
152 schema:givenName Michiko
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137320362.23
154 rdf:type schema:Person
155 sg:person.01215176214.31 schema:affiliation grid-institutes:grid.45203.30
156 schema:familyName Tokunaga
157 schema:givenName Katsushi
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215176214.31
159 rdf:type schema:Person
160 sg:person.01245676554.49 schema:affiliation grid-institutes:None
161 schema:familyName Yabe
162 schema:givenName Toshio
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245676554.49
164 rdf:type schema:Person
165 sg:person.015475136753.68 schema:affiliation grid-institutes:grid.410797.c
166 schema:familyName Nakamura
167 schema:givenName Ryosuke
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015475136753.68
169 rdf:type schema:Person
170 sg:person.0624777723.12 schema:affiliation grid-institutes:grid.272458.e
171 schema:familyName Sotozono
172 schema:givenName Chie
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624777723.12
174 rdf:type schema:Person
175 sg:person.0741220377.47 schema:affiliation grid-institutes:grid.410797.c
176 schema:familyName Saito
177 schema:givenName Yoshiro
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741220377.47
179 rdf:type schema:Person
180 sg:person.0741226323.70 schema:affiliation grid-institutes:grid.272458.e
181 schema:familyName Ueta
182 schema:givenName Mayumi
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741226323.70
184 rdf:type schema:Person
185 sg:pub.10.1038/ni1188 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005581325
186 https://doi.org/10.1038/ni1188
187 rdf:type schema:CreativeWork
188 sg:pub.10.1038/srep04862 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032179384
189 https://doi.org/10.1038/srep04862
190 rdf:type schema:CreativeWork
191 sg:pub.10.1038/srep05981 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003061255
192 https://doi.org/10.1038/srep05981
193 rdf:type schema:CreativeWork
194 grid-institutes:None schema:alternateName Tokyo Metropolitan Red Cross Blood Center, Tokyo, Japan
195 schema:name Tokyo Metropolitan Red Cross Blood Center, Tokyo, Japan
196 rdf:type schema:Organization
197 grid-institutes:grid.256115.4 schema:alternateName Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
198 schema:name Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
199 rdf:type schema:Organization
200 grid-institutes:grid.268441.d schema:alternateName Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
201 schema:name Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
202 rdf:type schema:Organization
203 grid-institutes:grid.272458.e schema:alternateName Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
204 Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
205 schema:name Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
206 Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
207 rdf:type schema:Organization
208 grid-institutes:grid.410797.c schema:alternateName Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan
209 schema:name Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan
210 rdf:type schema:Organization
211 grid-institutes:grid.45203.30 schema:alternateName Genome Medical Science Project (Toyama), National Center for Global Health and Medicine, Tokyo, Japan
212 schema:name Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
213 Genome Medical Science Project (Toyama), National Center for Global Health and Medicine, Tokyo, Japan
214 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...